Search research articles
Contact Us
Filters
Showing results (211-220 of 235) with videos related to
Page
of 24
Sort By:
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
Oral Oncology
|
September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease
Kathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Hepatology (Baltimore, Md.)
|
May 16, 2026
CD4+ T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis
Lucía Valenzuela-Pérez, Hyun Se Kim Lee, Rachel L Bayer, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
Hunter C Gits, Amy H Tang, William S Harmsen, et al.
JCI Insight
|
June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer
Luis F Flores, David L Marks, Renzo E Vera, et al.
Histopathology
|
January 31, 2025
Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects
Raul S Gonzalez, Rachel K Horton, Xuchen Zhang, et al.
Cancer Research Communications
|
May 6, 2024
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence
Frank A Sinicrope, Garth D Nelson, Bahar Saberzadeh-Ardestani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 2, 2017
Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
Rondell P Graham, Matthew M Yeh, Dora Lam-Himlin, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 235) with videos related to
Sort By:
Page
of 24
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
Oral Oncology
|
September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease
Kathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Hepatology (Baltimore, Md.)
|
May 16, 2026
CD4+ T cells promote fibrosis during metabolic dysfunction-associated steatohepatitis
Lucía Valenzuela-Pérez, Hyun Se Kim Lee, Rachel L Bayer, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
Hunter C Gits, Amy H Tang, William S Harmsen, et al.
JCI Insight
|
June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer
Luis F Flores, David L Marks, Renzo E Vera, et al.
Histopathology
|
January 31, 2025
Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects
Raul S Gonzalez, Rachel K Horton, Xuchen Zhang, et al.
Cancer Research Communications
|
May 6, 2024
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence
Frank A Sinicrope, Garth D Nelson, Bahar Saberzadeh-Ardestani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 2, 2017
Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
Rondell P Graham, Matthew M Yeh, Dora Lam-Himlin, et al.
Page
of 24